Keith Fredlake is a registered patent attorney who focuses his practice on intellectual property matters, including drafting and prosecuting patent applications, primarily in the chemical and life sciences industry including chemistry, chemical engineering, oil & gas-petrochemicals, medical devices and pharmaceuticals. Mr. Fredlake works with clients on design patents and he also counsels clients on issues regarding the patentability of inventions, patent rights in foreign countries, and the infringement and validity of U.S. patents.

Mr. Fredlake’s patent practice includes performing portfolio review for clients, including freedom-to-operate, invalidity, patentability and opposition searches. He is also experienced in the preparation of invalidity and non-infringement options for utility and design patents. In addition, Mr. Fredlake has significant experience in conducting trademark clearances, registering trademarks, negotiations and licensing, and adversarial proceedings before the U.S. Trademark and Appeal Board and Internet Corporation for Assigned Names and Numbers.

Prior to joining the firm, Mr. Fredlake worked as a shareholder a Northern Virginia office of an intellectual property law firm where his areas of practice included patents, opinions and searching. Previously, Mr. Fredlake was an associate in the Washington, D.C. office of an international law firm.

Mr. Fredlake was recommended by Legal 500 US in 2015 for Patent Prosecution.

Professional & Community Activities

Licensing Executive Society, CEEM Member


  • American University, J.D. (2002)
  • Western State College of Colorado, B.A., Political Science (1998)

Bar Admissions

  • District of Columbia (2008)
  • Virginia (2013)
  • Colorado (inactive) (2002)


  • U.S. Patent and Trademark Office (2005)
  • U.S. District Court for the District of Colorado

Who We Are

Suite 900, 607 14th Street, NW
Washington, DC, 20005-2018
t +1 202.481.9923
f +1 202.379.3473

Keith D. Fredlake

Experience Highlights

Daicel v. Celanese
Counsel for patentee Celanese in five inter partes review petitions filed by competitor Daicel challenging validity of Celanese patents related to more